We are live on ! Find out more
ZSAN

Zosano Pharma Corporation

Delisted

ZSAN was delisted on the 10th of June, 2022.

19 hedge funds and large institutions have $64.9M invested in Zosano Pharma Corporation in 2015 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+19
Holders Change %
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$21.8M +$23.1M +3,084 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.1M +$10.7M +1,429 New
EAM
3
Eventide Asset Management
Massachusetts
$8.38M +$8.88M +1,184 New
BC
4
Broadfin Capital
New York
$4.9M +$5.2M +693 New
VAM
5
Visium Asset Management
New York
$4.55M +$4.82M +643 New
PI
6
Putnam Investments
Massachusetts
$4.04M +$4.28M +571 New
LOAMU
7
Lombard Odier Asset Management (USA)
New York
$3.63M +$3.85M +513 New
PAI
8
ProQuest Associates IV
Florida
$2.32M +$2.46M +328 New
SFM
9
Sphera Funds Management
Israel
$1.87M +$1.98M +264 New
SM
10
Sabby Management
Florida
$1.43M +$1.52M +202 New
RA
11
Royce & Associates
New York
$910K +$968K +129 New
Millennium Management
12
Millennium Management
New York
$287K +$308K +41 New
ACP
13
Acuta Capital Partners
California
$222K +$233K +31 New
KCM
14
Knoll Capital Management
Florida
$202K +$218K +29 New
Morgan Stanley
15
Morgan Stanley
New York
$143K +$150K +20 New
Deutsche Bank
16
Deutsche Bank
Germany
$19K +$22.5K +3 New
BIT
17
BlackRock Institutional Trust
California
$16K +$15K +2 New
UBS Group
18
UBS Group
Switzerland
$9K +$7.5K +1 New
BIM
19
BlackRock Investment Management
Delaware
$6K +$7.5K +1 New
TRCT
20
Tower Research Capital (TRC)
New York
$3K
BG
21
BlackRock Group
United Kingdom
$2K

ZSAN Hedge Fund Activity: Q1 2015 in Review

19 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2015, worth a combined $64.9M.

Buyers outnumbered sellers: 19 funds opened new ZSAN positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $23.1M.

  • 19 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2015, up from 0 in Q4 2014.
  • Funds reported $64.9M of Zosano Pharma Corporation stock for Q1 2015.
  • 19 funds opened new Zosano Pharma Corporation positions in Q1 2015 and 0 closed out, a net change of +19 holders.
  • The largest Zosano Pharma Corporation buyer in Q1 2015 was NEA Management Company, an estimated $23.1M added.

Based on aggregated 13F filings for Q1 2015.